Chronic obstructive pulmonary disease (COPD) patients who do not have Siglec‐14 (a myeloid cell protein that triggers inflammatory responses) are less prone to exacerbation of the disease. Here, SIGLEC14 is linked to chronic obstructive pulmonary disease.